Skip to main content
Top
Published in: BMC Medical Genetics 1/2009

Open Access 01-12-2009 | Research article

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels

Authors: Katarina Domanska, Christina Carlsson, Pär-Ola Bendahl, Mef Nilbert

Published in: BMC Medical Genetics | Issue 1/2009

Login to get access

Abstract

Background

Identification and adequate management of individuals at risk for hereditary nonpolyposis colorectal cancer (HNPCC) is crucial since surveillance programmes reduce morbidity and mortality. We investigated knowledge about key features of HNPCC in at risk individuals and physicians in surgery, gynecology and oncology.

Methods

Data were collected using a questionnaire which was answered by 67 mutation carriers and 102 physicians from the southern Swedish health care region. The statements were related to colorectal cancer, heredity and surveillance and the physicians were also asked questions about cancer risks and surveillance strategies.

Results

Both groups answered questions on colorectal cancer risk, surveillance and genetic testing well, whereas answers about inheritance and risks for HNPCC associated cancer were less accurate. Only half of the family members and one third of the physicians correctly estimated the risk to inherit an HNPCC predisposing mutation. Among family members, young age (<57 years), female sex and recent genetic counseling significantly correlated with better results. Physicians generally underestimated the risk of HNPCC associated cancers and three out of four suggested a later starting age for surveillance than recommended.

Conclusion

The finding of similar levels of knowledge about key features of HNPCC in at risk individuals and physicians reflect the challenge physicians face in keeping up to date on hereditary cancer and may have implications for the clinical management and professional relations with HNPCC family members.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG: Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2004, 22 (1): 39-44. 10.1200/JCO.2004.06.128.CrossRefPubMed Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG: Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2004, 22 (1): 39-44. 10.1200/JCO.2004.06.128.CrossRefPubMed
2.
go back to reference Wagner A, Tops C, Wijnen JT, Zwinderman K, Meer van der C, Kets M, Niermeijer MF, Klijn JG, Tibben A, Vasen HF, et al: Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet. 2002, 39 (11): 833-837. 10.1136/jmg.39.11.833.CrossRefPubMedPubMedCentral Wagner A, Tops C, Wijnen JT, Zwinderman K, Meer van der C, Kets M, Niermeijer MF, Klijn JG, Tibben A, Vasen HF, et al: Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet. 2002, 39 (11): 833-837. 10.1136/jmg.39.11.833.CrossRefPubMedPubMedCentral
3.
go back to reference Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB: Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol. 2007, 110 (1): 18-25.CrossRefPubMed Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB: Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol. 2007, 110 (1): 18-25.CrossRefPubMed
4.
go back to reference Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ: Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007, 107 (2): 159-162. 10.1016/j.ygyno.2007.09.031.CrossRefPubMed Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ: Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007, 107 (2): 159-162. 10.1016/j.ygyno.2007.09.031.CrossRefPubMed
5.
go back to reference Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, et al: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007, 44 (6): 353-362. 10.1136/jmg.2007.048991.CrossRefPubMedPubMedCentral Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, et al: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007, 44 (6): 353-362. 10.1136/jmg.2007.048991.CrossRefPubMedPubMedCentral
6.
go back to reference Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006, 296 (12): 1507-1517. 10.1001/jama.296.12.1507.CrossRefPubMed Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006, 296 (12): 1507-1517. 10.1001/jama.296.12.1507.CrossRefPubMed
7.
go back to reference Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E: Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns. 2004, 55 (2): 265-274. 10.1016/j.pec.2003.11.002.CrossRefPubMed Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E: Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns. 2004, 55 (2): 265-274. 10.1016/j.pec.2003.11.002.CrossRefPubMed
8.
go back to reference Vernon SW: Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr. 1999, 101-119. 25 Vernon SW: Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr. 1999, 101-119. 25
9.
go back to reference de la Chapelle A: The incidence of Lynch syndrome. Fam Cancer. 2005, 4 (3): 233-237. 10.1007/s10689-004-5811-3.CrossRefPubMed de la Chapelle A: The incidence of Lynch syndrome. Fam Cancer. 2005, 4 (3): 233-237. 10.1007/s10689-004-5811-3.CrossRefPubMed
10.
go back to reference Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999, 81 (2): 214-218. 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L.CrossRefPubMed Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999, 81 (2): 214-218. 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L.CrossRefPubMed
11.
go back to reference Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet. 2008, 74 (3): 233-242. 10.1111/j.1399-0004.2008.01035.x.CrossRefPubMed Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet. 2008, 74 (3): 233-242. 10.1111/j.1399-0004.2008.01035.x.CrossRefPubMed
13.
go back to reference Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997, 6 (1): 105-110. 10.1093/hmg/6.1.105.CrossRefPubMed Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997, 6 (1): 105-110. 10.1093/hmg/6.1.105.CrossRefPubMed
14.
go back to reference Watson P, Butzow R, Lynch HT, Mecklin JP, Jarvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I: The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol. 2001, 82 (2): 223-228. 10.1006/gyno.2001.6279.CrossRefPubMed Watson P, Butzow R, Lynch HT, Mecklin JP, Jarvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I: The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol. 2001, 82 (2): 223-228. 10.1006/gyno.2001.6279.CrossRefPubMed
15.
go back to reference Vasen HF, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Houwing-Duistermaat JJ, Meera Khan P: The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer. 1996, 65 (4): 422-425. 10.1002/(SICI)1097-0215(19960208)65:4<422::AID-IJC4>3.0.CO;2-Z.CrossRefPubMed Vasen HF, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Houwing-Duistermaat JJ, Meera Khan P: The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer. 1996, 65 (4): 422-425. 10.1002/(SICI)1097-0215(19960208)65:4<422::AID-IJC4>3.0.CO;2-Z.CrossRefPubMed
16.
go back to reference Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, et al: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996, 110 (4): 1020-1027. 10.1053/gast.1996.v110.pm8612988.CrossRefPubMed Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, et al: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996, 110 (4): 1020-1027. 10.1053/gast.1996.v110.pm8612988.CrossRefPubMed
17.
go back to reference Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF: Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol. 1998, 160 (2): 466-470. 10.1016/S0022-5347(01)62926-4.CrossRefPubMed Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF: Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol. 1998, 160 (2): 466-470. 10.1016/S0022-5347(01)62926-4.CrossRefPubMed
18.
go back to reference Murphy HR, Armstrong R, Cairns D, Greenhalgh KL: Muir-Torre Syndrome: expanding the genotype and phenotype – a further family with a MSH6 mutation. Fam Cancer. 2008, 7 (3): 255-257. 10.1007/s10689-008-9183-y.CrossRefPubMed Murphy HR, Armstrong R, Cairns D, Greenhalgh KL: Muir-Torre Syndrome: expanding the genotype and phenotype – a further family with a MSH6 mutation. Fam Cancer. 2008, 7 (3): 255-257. 10.1007/s10689-008-9183-y.CrossRefPubMed
19.
go back to reference Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999, 116 (6): 1453-1456. 10.1016/S0016-5085(99)70510-X.CrossRefPubMed Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999, 116 (6): 1453-1456. 10.1016/S0016-5085(99)70510-X.CrossRefPubMed
20.
go back to reference Rodriguez-Bigas MA: Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997, 84 (7): 1027-1028. 10.1002/bjs.1800840739.CrossRefPubMed Rodriguez-Bigas MA: Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997, 84 (7): 1027-1028. 10.1002/bjs.1800840739.CrossRefPubMed
21.
go back to reference Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004, 96 (4): 261-268.CrossRefPubMedPubMedCentral Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004, 96 (4): 261-268.CrossRefPubMedPubMedCentral
22.
go back to reference Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P: A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998, 82 (9): 1632-1637. 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.0.CO;2-C.CrossRefPubMed Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P: A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998, 82 (9): 1632-1637. 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.0.CO;2-C.CrossRefPubMed
23.
go back to reference Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000, 118 (5): 829-834. 10.1016/S0016-5085(00)70168-5.CrossRefPubMed Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000, 118 (5): 829-834. 10.1016/S0016-5085(00)70168-5.CrossRefPubMed
24.
go back to reference Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006, 354 (3): 261-269. 10.1056/NEJMoa052627.CrossRefPubMed Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006, 354 (3): 261-269. 10.1056/NEJMoa052627.CrossRefPubMed
25.
go back to reference Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Brocker-Vriends AH: Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006, 56 (4): 213-225. 10.3322/canjclin.56.4.213.CrossRefPubMed Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Brocker-Vriends AH: Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006, 56 (4): 213-225. 10.3322/canjclin.56.4.213.CrossRefPubMed
26.
go back to reference Johnson KA, Trimbath JD, Petersen GM, Griffin CA, Giardiello FM: Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test. 2002, 6 (4): 303-306. 10.1089/10906570260471831.CrossRefPubMed Johnson KA, Trimbath JD, Petersen GM, Griffin CA, Giardiello FM: Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test. 2002, 6 (4): 303-306. 10.1089/10906570260471831.CrossRefPubMed
27.
go back to reference Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K: Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002, 97 (3): 729-733. 10.1111/j.1572-0241.2002.05556.x.CrossRefPubMed Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K: Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002, 97 (3): 729-733. 10.1111/j.1572-0241.2002.05556.x.CrossRefPubMed
28.
go back to reference Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC: Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002, 97 (4): 1031-1036. 10.1111/j.1572-0241.2002.05624.x.CrossRefPubMed Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC: Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002, 97 (4): 1031-1036. 10.1111/j.1572-0241.2002.05624.x.CrossRefPubMed
30.
go back to reference Lynch PM: New issues in genetic counseling of hereditary colon cancer. Clin Cancer Res. 2007, 13 (22 Pt 2): 6857s-6861s. 10.1158/1078-0432.CCR-07-1124.CrossRefPubMed Lynch PM: New issues in genetic counseling of hereditary colon cancer. Clin Cancer Res. 2007, 13 (22 Pt 2): 6857s-6861s. 10.1158/1078-0432.CCR-07-1124.CrossRefPubMed
31.
go back to reference Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN: Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005, 42 (10): 749-755. 10.1136/jmg.2004.030296.CrossRefPubMedPubMedCentral Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN: Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005, 42 (10): 749-755. 10.1136/jmg.2004.030296.CrossRefPubMedPubMedCentral
32.
go back to reference Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT: Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A. 2004, 125A (1): 5-11. 10.1002/ajmg.a.20431.CrossRefPubMed Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT: Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A. 2004, 125A (1): 5-11. 10.1002/ajmg.a.20431.CrossRefPubMed
33.
go back to reference Gilbert A, Kanarek N: Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev Med. 2005, 41 (2): 367-379. 10.1016/j.ypmed.2005.01.008.CrossRefPubMed Gilbert A, Kanarek N: Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev Med. 2005, 41 (2): 367-379. 10.1016/j.ypmed.2005.01.008.CrossRefPubMed
Metadata
Title
Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels
Authors
Katarina Domanska
Christina Carlsson
Pär-Ola Bendahl
Mef Nilbert
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2009
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-10-30

Other articles of this Issue 1/2009

BMC Medical Genetics 1/2009 Go to the issue